These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36318038)

  • 21. Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects.
    Das T; Nandy S; Ghosh A; Chandran D; Sharma AK; Dhama K; Dey A
    Int J Surg; 2023 May; 109(5):1528-1530. PubMed ID: 36974695
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.
    Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat.
    Nunes DDS; Higa LM; Oliveira RL; da Costa LC; Bomfim LM; Gonçalves CCA; Mariani D; Hruby DE; Voloch CM; Castiñeiras TMPP; Tanuri A; Damaso CR
    Mem Inst Oswaldo Cruz; 2023; 118():e230056. PubMed ID: 37436275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus.
    Schultz DA; Sagartz JE; Huso DL; Buller RM
    Virology; 2009 Jan; 383(1):86-92. PubMed ID: 18977501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation.
    Realegeno S; Puschnik AS; Kumar A; Goldsmith C; Burgado J; Sambhara S; Olson VA; Carroll D; Damon I; Hirata T; Kinoshita T; Carette JE; Satheshkumar PS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331092
    [No Abstract]   [Full Text] [Related]  

  • 26. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
    Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monkeypox virus: a re-emergent threat to humans.
    Gong Q; Wang C; Chuai X; Chiu S
    Virol Sin; 2022 Aug; 37(4):477-482. PubMed ID: 35820590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
    Stittelaar KJ; Neyts J; Naesens L; van Amerongen G; van Lavieren RF; Holý A; De Clercq E; Niesters HG; Fries E; Maas C; Mulder PG; van der Zeijst BA; Osterhaus AD
    Nature; 2006 Feb; 439(7077):745-8. PubMed ID: 16341204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II.
    Criscuolo E; Giuliani B; Ferrarese R; Ferrari D; Locatelli M; Clementi M; Mancini N; Clementi N
    J Med Virol; 2023 Mar; 95(3):e28643. PubMed ID: 36890648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmissibility of the monkeypox virus clades via respiratory transmission: investigation using the prairie dog-monkeypox virus challenge system.
    Hutson CL; Gallardo-Romero N; Carroll DS; Clemmons C; Salzer JS; Nagy T; Hughes CM; Olson VA; Karem KL; Damon IK
    PLoS One; 2013; 8(2):e55488. PubMed ID: 23408990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mpox Virus and its ocular surface manifestations.
    Chakravarty N; Hemani D; Paravastu R; Ahmad Z; Palani SN; Arumugaswami V; Kumar A
    Ocul Surf; 2024 Oct; 34():108-121. PubMed ID: 38972544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.
    Russo AT; Grosenbach DW; Chinsangaram J; Honeychurch KM; Long PG; Lovejoy C; Maiti B; Meara I; Hruby DE
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):331-344. PubMed ID: 32882158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monkeypox treatment: Current evidence and future perspectives.
    Khani E; Afsharirad B; Entezari-Maleki T
    J Med Virol; 2023 Jan; 95(1):e28229. PubMed ID: 36253931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monkeypox disease transmission in an experimental setting: prairie dog animal model.
    Hutson CL; Carroll DS; Gallardo-Romero N; Weiss S; Clemmons C; Hughes CM; Salzer JS; Olson VA; Abel J; Karem KL; Damon IK
    PLoS One; 2011; 6(12):e28295. PubMed ID: 22164263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supervised screening of Tecovirimat-like compounds as potential inhibitors for the monkeypox virus E8L protein.
    Mehmood A; Nawab S; Jia G; Kaushik AC; Wei DQ
    J Biomol Struct Dyn; 2024 Sep; 42(15):8100-8113. PubMed ID: 37561169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monkeypox infection: The past, present, and future.
    Upadhayay S; Arthur R; Soni D; Yadav P; Navik U; Singh R; Gurjeet Singh T; Kumar P
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109382. PubMed ID: 36330915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virological characterization of the 2022 outbreak-causing monkeypox virus using human keratinocytes and colon organoids.
    Watanabe Y; Kimura I; Hashimoto R; Sakamoto A; Yasuhara N; Yamamoto T; ; Sato K; Takayama K
    J Med Virol; 2023 Jun; 95(6):e28827. PubMed ID: 37278443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022.
    Wang L; Shang J; Weng S; Aliyari SR; Ji C; Cheng G; Wu A
    J Med Virol; 2023 Jan; 95(1):e28036. PubMed ID: 35906185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of monkeypox viruses pathogenesis in mice by in vivo imaging.
    Osorio JE; Iams KP; Meteyer CU; Rocke TE
    PLoS One; 2009 Aug; 4(8):e6592. PubMed ID: 19668372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using the Ground Squirrel (Marmota bobak) as an Animal Model to Assess Monkeypox Drug Efficacy.
    Sergeev AA; Kabanov AS; Bulychev LE; Sergeev AA; Pyankov OV; Bodnev SA; Galahova DO; Zamedyanskaya AS; Titova KA; Glotova TI; Taranov OS; Omigov VV; Shishkina LN; Agafonov AP; Sergeev AN
    Transbound Emerg Dis; 2017 Feb; 64(1):226-236. PubMed ID: 25944444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.